Athenex: Athenex files for bankruptcy, announces plans to sell assets
After two years of trying to regain its financial footing, Athenex files for bankruptcy.
Read full article »
Athenex is a biopharmaceutical company that develops novel immune cell therapies for the treatment of cancer and inflammatory diseases.
Read more